新闻发布

07.11.2019 | Nanion and Assay.Works Partner to offer Drug Discovery Services for Membrane Transporter Targets

Munich, Germany, November 7th 2019: Nanion Technologies, a leading provider of automated electrophysiology systems, today announced its partnership with Assay.Works, experts in assay development and High Throughput Screening (HTS), who will be providing SURFE²R 96SE assays “As-a-Service” for membrane transporter research.
Membrane transport proteins, enabling active and secondary active transport of ions and solutes across the membrane, are important drug targets but may also be involved in unwanted side effects of novel drug candidates. As response to the growing demand in assay options for membrane transporters and to afford researchers access to SSM-based electrophysiology, Nanion and Assay.Works have entered into a partnership.

Continue Reading

31.10.2019 | Press release SURFE²R N1 Research Grant Winners

MUNICH, GERMANY, October 31st 2019: Nanion is pleased to announce not one, but two winners of the SURFE²R N1 grant award. The two winners: Dr. Camilo Perez (The Center for Molecular Life Sciences, University of Basel, Switzerland) and Dr. Dimitrios Fotiadis (Institute for Biochemistry and Molecular Medicine, University of Bern, Switzerland) convinced the grant committee with their proposed research projects on nanobodies inhibiting membrane transporters and the deorphanization and investigation of a group of transporters involved in antibiotic transport, respectively.

Continue Reading

Cookies make it easier for us to provide you with our services. With the usage of our services you permit us to use cookies.